Compugen (Israel) Investor Sentiment

CGEN Stock  ILA 584.00  2.00  0.34%   
About 62% of Compugen's investor base is looking to short. The analysis of current outlook of investing in Compugen suggests that many traders are alarmed regarding Compugen's prospects. The current market sentiment, together with Compugen's historical and current headlines, can help investors time the market. In addition, many technical investors use Compugen stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at news.google.com         
Compugen Ltd. Given Average Recommendation of Moderate Buy by Brokerages - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Compugen Ltd. is up 3.21 percent Wednesday In Premarket Trading - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
5 Growth Stocks Under 10 to Scoop Up Now - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Where Will Compugen Ltd. Stock Go Next After It Has Gained 4.44 percent in a Week - InvestorsObserve...
Google News at Macroaxis
over a year ago at news.google.com         
Compugen regains compliance with Nasdaqs minimum bid price requirement - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Compugen Ltd. Receives Consensus Recommendation of Moderate Buy from Analysts - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
What is the Markets View on Compugen Ltd. Stocks Price and Volume Trends Tuesday - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Should You Hold Compugen Ltd. Stock Friday Morning - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Premarket Mover Compugen Ltd. Down 5.41 percent - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Premarket Mover Compugen Ltd. Up 2.50 percent - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Gilead, Compugen Ink Potential 848M Deal for Preclinical Immunotherapy - BioSpace
Google News at Macroaxis
over a year ago at news.google.com         
Is Compugen Outperforming Other Medical Stocks This Year - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Will Compugen Spend Its Cash Wisely - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Gli EPS di Compugen hanno mancato le aspettative, il fatturato in ... - Investing.com Italia
Google News at Macroaxis
over a year ago at news.google.com         
Compugen Announces Receipt of Nasdaq Minimum Bid Price Notification - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Compugen that are available to investors today. That information is available publicly through Compugen media outlets and privately through word of mouth or via Compugen internal channels. However, regardless of the origin, that massive amount of Compugen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Compugen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Compugen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Compugen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Compugen alpha.

Compugen Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements